StockData
Neogen Corp logo

Neogen Corp (NEOG) stock

NEOGNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 7, 2026Score 7/3049% above fair value
$11.08+0.18 (+1.65%)

Close on Nov 18, 2026Market cap $2.42BP/E –Yield –

Neogen pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Neogen's pe ratio was 263.0× on Mar 28, 2024, against 31.0× a year earlier. Over the last 5 years it ranged from 31.0× to 543.8×, with a median of 64.7×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Mar 28, 2024263.0×−280.8
2023Jun 30, 2023543.8×+499.0
2022Dec 30, 202244.8×−33.5
2021Dec 31, 202178.3×+7.5
2020Dec 31, 202070.8×+13.6
2019Dec 31, 201957.2×+12.4
2018Dec 31, 201844.9×−24.4
2017Dec 29, 201769.3×−19.9
2016Dec 30, 201689.2×+6.4
2015Dec 31, 201582.8×−0.9
2014Dec 31, 201483.7×+4.6
2013Dec 31, 201379.1×+17.2
2012Dec 31, 201262.0×+19.9
2011Dec 30, 201142.1×−29.9
2010Dec 31, 201072.0×–

More Neogen figures

See a number that looks wrong?